Responsible for global p&l spanning operations in USA, Ireland and Israel.

Major supplier of semiconductor and medical device process equipment parts cleaning and refurbishment. Full P&L responsibility for New York facility and Northeast region.

Working with entrepreneurs and inventors at Columbia University to facilitate the transfer of research innovations from the lab to the market, as well as supporting start-up efforts. Columbia Technology Ventures, the technology transfer office of Columbia University, manages more than 350 invention disclosures from faculty, 100 license deals and 20 new start-ups each year. CTV currently has over 1200 patent assets available for licensing across research fields such as bio, IT, cleantech, devices, nanotechnology, and material science. To learn more about CTV and available inventions, please visit www.techventures.columbia.edu.

Recruited by CTO to return to the company to accelerate revenue growth and profits from R&D investments. Global responsibility for applications including electronics, water treatment, biopharma, food and beverage, metallurgy, hydrogen for fuel cells, semiconductor DUV and industrial lasers, and others. Key performance indicator was new revenue generation through business development, emerging product prioritization and new opportunity identification. Developed financial models, trained and worked directly with sales force, created launch packages and marketing programs for new products. • By prioritizing and refining new product offering value propositions consistently generated $125-150 million / year in revenues from new products.• Through business development and replication of successful product approaches across business regions increased sales from products less than 5 years old to 3% of total.• Broke down barriers to adoption by forging relationships with other parties in the value chain to accelerate revenue growth, especially in Asia.• Identified opportunities to expand company’s product portfolio through strategic sourcing resulting in more than $25 million / year in new sales. Received special recognition award.• Leveraged industry growth trends to secure product qualifications critical to product adoption resulting in $15 million / year in additional sales.

Asked by Executive Chairman and Board to turn around a struggling startup. Full responsibility for company performance and operations as well as investor relations and funding.• Within a year, clarified company value proposition to establish “go to market” global partnerships with 3 of the 5 largest players in target market and channel. • Led the team to launch company’s first commercial product ranked 8th in Electronic Design’s Top 101 Emerging Components. • Raised over $20 M in financing from venture capital sources. Business eventually sold.

Full P&L responsibility for multiple business units (biopharma/pharma packages and equipment, chemical packaging, gas products and advanced chemistry. Tripled top and bottom line revenues within 4 years through accelerated market penetration. Created value propositions to respond to threat of competitive entry and expand business into additional verticals.• Through focus on product development and introduction revitalized company with over 30% of all sales coming from products less than 2 years old.• Championed opportunity to create customer value by expanding parenteral drug sterilization capabilities into one-time-use biopharma processing. Business successfully divested in trade sale.• Began joint operations with potential Japanese competitor to enhance customer service and grow Asia revenues by $20-30 million / year.• Targeted and executed 2 acquisitions that transformed parent company from equipment to consumable materials supplier.